Effectiveness of Adding Relapse Prevention Cognitive Behavioral Therapy to Fluoxetine Treatment for Pediatric Major Depressive Disorder - Contacts and Locations

Effectiveness of Adding Relapse Prevention Cognitive Behavioral Therapy to Fluoxetine Treatment for Pediatric Major Depressive Disorder

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00612313

Contacts


Contact: Jaime Murphy, BA	214-456-8918	jaime.murphy@utsouthwestern.edu

Locations


United States, Texas
	Children's Medical Center of Dallas, Outpatient Psychiatry Clinic	Recruiting
	Dallas, Texas, United States, 75235
	Principal Investigator: Graham J. Emslie, MD
	Principal Investigator: Beth D. Kennard, PsyD
	Sub-Investigator: Rongrong Tao, MD, PhD

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	Graham J. Emslie, MD	University of Texas Southwestern Medical Center at Dallas

Principal Investigator:	Beth D. Kennard, PsyD	University of Texas Southwestern Medical Center at Dallas